Multiplex Assay Kit for Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array)

CD309; FLK1; VEGFR; KDR; A Type III Receptor Tyrosine Kinase; Kinase Insert Domain Receptor; Kinase Insert Domain Receptor; Fetal Liver Kinase-1

Specificity

This assay has high sensitivity and excellent specificity for detection of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 85-98 92
EDTA plasma(n=5) 80-99 92
heparin plasma(n=5) 82-93 90

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-103% 85-101% 82-92% 86-95%
EDTA plasma(n=5) 86-101% 88-97% 91-98% 93-103%
heparin plasma(n=5) 93-101% 95-104% 92-101% 78-93%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
APMIS Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway PubMed: 23398358
Acta Biomater Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study PubMed: 26689470
Acta Biomaterialia Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study Pubmed:26689470
Journal of Cellular Physiology A Human 3D In Vitro Model to Assess the Relationship Between Osteoporosis and Disseminationto Bone of Breast Cancer Tumor Cells. pubmed:27925188
Regenerative Biomaterials The directional migration and differentiation of mesenchymal stem cells toward vascular endothelial cells stimulated by biphasic calcium phosphate ceramic 10.1093/rb/rbx028
International Journal of Immunopathology and Pharmacology VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these … Pubmed:29985074
JOURNAL OF DERMATOLOGICAL TREATMENT Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris Pubmed: 32043381
Journal of Genetic Engineering and Biotechnology Encapsulated VEGF 121-PLA microparticles promote angiogenesis in human endometrium stromal cells 33523322
Mol Cell Biochem Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy 34324118
BMC Nephrol Effect of subacute poisoning with lambdacyhalothrin on vascular endothelial growth factor 2 receptor in mice kidneys Pubmed:35643467
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB367Hu61 Active Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Cell culture; Activity Assays.
EPB367Hu61 Eukaryotic Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Positive Control; Immunogen; SDS-PAGE; WB.
APB367Hu01 Active Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Cell culture; Activity Assays.
RPB367Hu01 Recombinant Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Positive Control; Immunogen; SDS-PAGE; WB.
PAB367Hu01 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) WB; ICC/IF
LAB367Hu81 FITC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) WB; IHC; ICC; IF.
LAB367Hu71 Biotin-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) WB; IHC; ICC.
FAB367Hu51 APC-Linked Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Polyclonal Antibody FCM
MAB367Hu23 Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ICC/IF
MAB367Hu26 Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) WB; ICC/IF
RAB367Hu21 Recombinant Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) WB; IF; ICC; IHC; IP; FCM.
MAB367Hu22 Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) WB; ICC/IF
MAB367Hu24 Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ICC/IF
MAB367Hu21 Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ICC/IF
FAB367Hu32 APC/Cy7-Linked Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Monoclonal Antibody FCM
FAB367Hu82 FITC-Linked Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Monoclonal Antibody Flow cytometry.
HEB367Hu High Sensitive ELISA Kit for Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Enzyme-linked immunosorbent assay for Antigen Detection.
SEB367Hu ELISA Kit for Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB367Hu Multiplex Assay Kit for Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMB367Hu Multiplex Assay Kit for Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
KSB367Hu01 ELISA Kit DIY Materials for Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Main materials for "Do It(ELISA Kit) Yourself"